Patents by Inventor Steven Paul WEINSTEIN

Steven Paul WEINSTEIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230058395
    Abstract: The present invention provides methods for treating atopic dermatitis (AD). Also provided are methods for improving one or more AD-associated parameter(s), and methods for decreasing the level of at least one AD-associated biomarker in a subject in need thereof. The methods of the present invention comprise administering to a subject in need thereof a pharmaceutical composition comprising an interleukin-4 receptor (IL-4R) antagonist such as an anti-IL-4R antibody.
    Type: Application
    Filed: September 23, 2022
    Publication date: February 23, 2023
    Inventors: Marius ARDELEANU, Neil GRAHAM, Jennifer Davidson HAMILTON, Stephane C. KIRKESSELI, Sudeep KUNDU, Jeffrey MING, Allen RADIN, Ross E. ROCKLIN, Steven Paul WEINSTEIN
  • Publication number: 20170333557
    Abstract: The present invention provides methods for treating atopic dermatitis (AD). Also provided are methods for improving one or more AD-associated parameter(s), and methods for decreasing the level of at least one AD-associated biomarker in a subject in need thereof. The methods of the present invention comprise administering to a subject in need thereof a pharmaceutical composition comprising an interleukin-4 receptor (IL-4R) antagonist such as an anti-IL-4R antibody.
    Type: Application
    Filed: May 31, 2017
    Publication date: November 23, 2017
    Inventors: Marius ARDELEANU, Neil GRAHAM, Jennifer Davidson HAMILTON, Stephane C. KIRKESSELI, Sudeep KUNDU, Jeffrey MING, Allen RADIN, Ross E. ROCKLIN, Steven Paul WEINSTEIN
  • Publication number: 20140072583
    Abstract: The present invention provides methods for treating atopic dermatitis (AD). Also provided are methods for improving one or more AD-associated parameter(s), and methods for decreasing the level of at least one AD-associated biomarker in a subject in need thereof. The methods of the present invention comprise administering to a subject in need thereof a pharmaceutical composition comprising an interleukin-4 receptor (IL-4R) antagonist such as an anti-IL-4R antibody.
    Type: Application
    Filed: September 4, 2013
    Publication date: March 13, 2014
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Marius ARDELEANU, Neil GRAHAM, Jennifer Davidson HAMILTON, Stephane C. KIRKESSELI, Sudeep KUNDU, Jeffrey MING, Allen RADIN, Ross E. ROCKLIN, Steven Paul WEINSTEIN